Grants and Contributions

The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

• The Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) will fund applications that are determined to be relevant to the key research needs and objectives of CEEHRC.

The specific objectives of this funding opportunity are to:

• Generate relevant and timely evidence about the impacts of innovations in how healthcare systems and services are organized, delivered, governed, held accountable, financed, and/or funded on the Quadruple Aim goals and equity, and which innovations have the most potential for transformative impact in the Canadian context;
• Respond to a policy and/or decision maker’s evidence needs and help to inform decisions, policies or actions that advance achievement of the Quadruple Aim goals and health equity for all; and
• Catalyze future transformative, collaborative research between researchers, policy and/or decision makers, healthcare providers and patients that can be pursued through CIHR’s Project Grant competition or other relevant strategic funding competitions.

The specific objectives of this funding opportunity are to:

• Generate relevant and timely evidence about the impacts of innovations in how healthcare systems and services are organized, delivered, governed, held accountable, financed, and/or funded on the Quadruple Aim goals and equity, and which innovations have the most potential for transformative impact in the Canadian context;
• Respond to a policy and/or decision maker’s evidence needs and help to inform decisions, policies or actions that advance achievement of the Quadruple Aim goals and health equity for all; and
• Catalyze future transformative, collaborative research between researchers, policy and/or decision makers, healthcare providers and patients that can be pursued through CIHR’s Project Grant competition or other relevant strategic funding competitions.

The specific objectives of this funding opportunity are to:

Research, identify, address and/or share best and wise program and policy practices, and/or critical knowledge gaps, including the collection and management and analysis of high-quality and real-time data, related to addressing the immediate impacts and future consequences of COVID-19, among distinct Indigenous populations, communities and individuals;
Research and enable a comprehensive and timely understanding of the implications and impact of COVID-19, including emerging variants and the long COVID condition, within distinct Indigenous communities, and their relevance for public health, health systems and policy;
Identify, implement, evaluate and/or share culturally safe, distinctions-based and Indigenous-led and/or Indigenous community-led solutions to address the COVID-19 pandemic and its consequences, among Indigenous communities;
Accelerate distinctions-based and Indigenous-led and/or Indigenous community-led research and knowledge mobilization activities related to COVID-19 within the context of Indigenous health while supporting Indigenous community capacity development in research and knowledge mobilization; and
Expand or adapt existing programs and infrastructure, in Indigenous communities to support capacity development of Indigenous communities to design, lead, and meaningfully participate in culturally safe responses to the current COVID-19 pandemic and/or future pandemic preparedness.

The specific objective of this funding opportunity is to generate and share knowledge that will achieve one or more of the following:

Improve understanding of barriers to and opportunities for positive physical, social, and mental health outcomes for LGBTQIA/2S individuals, families and communities whose health is impacted by the intersections of their sexual orientation, gender, race/ethnicity, experiences of racism, and/or additional intersecting social identities, positions and processes, including but not limited to ableism, age, classism, disability, faith, heterosexism, homophobia, immigrant and/or refugee status, Indigeneity, language, transphobia and xenophobia.
Inform the implementation and/or sustainability and scale-up of new or existing community-based interventions to improve health and wellness for LGBTQIA/2S communities from an intersectional perspective.
Evaluate the reach, effectiveness, and benefits of community-based interventions to improve health and wellness for LGBTQIA/2S communities from an intersectional perspective.

The Institute of Cancer Research (ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. This priority announcement will fund research in the following research areas:
New methods and innovations in Breast Cancer Screening.
Early detection of high risk populations for Breast Cancer.

The Institute of Cancer Research (ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. This priority announcement will fund research in the following research areas:
New methods and innovations in Breast Cancer Screening.
Early detection of high risk populations for Breast Cancer.

• The CIHR HIV/AIDS Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged.
• This priority announcement will fund one (1) early career investigator for a total of three (3) years

The CIHR-IPPH Trailblazer Award is designed to recognize the exemplary efforts and activities of exceptional Canadian researchers at different career stages who have created a highly influential body of work that has had a substantial impact on the field of population and public health research. The award also recognizes the leadership, mentorship, and innovative contributions of the recipients.